Skip to content

RISS Block for Enhanced Recovery After Video-Assisted Thoracoscopic Surgery

A Prospective Randomized Controlled Trial Evaluating the Efficacy and Safety of Ultrasound-Guided Rhomboid Intercostal and Subserratus Plane Block for Enhanced Recovery After Video-Assisted Thoracoscopic Surgery

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07462273
Enrollment
90
Registered
2026-03-10
Start date
2024-09-01
Completion date
2025-10-01
Last updated
2026-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Thoracic Surgery, Video-Assisted Thoracic Surgery

Brief summary

This prospective randomized controlled trial evaluates the efficacy and safety of ultrasound-guided rhomboid intercostal and subserratus plane (RISS) block for postoperative analgesia in patients undergoing video-assisted thoracoscopic surgery (VATS). Postoperative pain after VATS can impair respiratory function, delay mobilization, and increase opioid consumption. Although several regional anesthesia techniques are available, the optimal analgesic strategy remains under investigation. The RISS block is a novel fascial plane block that may provide effective thoracic analgesia while minimizing opioid-related adverse effects. A total of 90 adult patients scheduled for elective VATS will be randomly assigned to receive either ultrasound-guided RISS block combined with general anesthesia or general anesthesia alone. The primary outcomes include postoperative 24-hour benefit of analgesia score (BCS) and patient-controlled intravenous analgesia (PCIA) pressing frequency. Secondary outcomes include postoperative pain scores, opioid consumption, and adverse events. This study aims to determine whether RISS block improves postoperative recovery and reduces opioid requirements after VATS.

Interventions

Ultrasound-guided dual-plane RISS block performed after induction of general anesthesia. A total of 40 mL of 0.375% ropivacaine (150 mg) was administered across the rhomboid-intercostal plane and low subserratus plane.

Ultrasound-guided intercostal nerve block performed at surgical port levels (T4-T7) using 0.375% ropivacaine with total dose ≤75 mg.

Sponsors

Ningbo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults aged 18 years or older ASA physical status I-II Scheduled for elective video-assisted thoracoscopic surgery (VATS) Provided written informed consent

Exclusion criteria

History of shock or coma Coagulopathy Local infection at the puncture site Pre-existing nerve injury on the side intended for block Chronic analgesic use Psychiatric disorders Prior thoracic or breast surgery Allergy to local or general anaesthetic agents Body mass index (BMI) ≥35 kg/m² Inability to operate a patient-controlled analgesia (PCA) device

Design outcomes

Primary

MeasureTime frame
24-hour cumulative number of effective PCA pressesWithin 24 hours postoperatively
Bruggrmann Comfort Scale (BCS) score at 24 hours24 hours after surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026